Patents by Inventor John J. Majnarich

John J. Majnarich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5895758
    Abstract: The invention relates to a biologically pure strain of L. plantarum, L. plantarum, OM. The L. plantarum, OM strain has proteolytic, anti-viral, anti-retroviral, anti-bacterial, anti-microbial, and anti-tumoral characteristics and uses. Thus, the invention relates to agents having proteolytic, anti-viral, anti-retroviral, anti-bacterial, anti-microbial, and anti-tumoral agents, having the respective capabilities. With respect to its anti-viral capability, the provided strain includes the capacity to screen a pharmaceutical agent to determine whether the pharmaceutical agent has any anti-retrovirus activity. The invention also relates to a nutritional supplement having proteolytic activity and utilizing the L. plantarum, OM ATCC 55981 strain.
    Type: Grant
    Filed: June 10, 1997
    Date of Patent: April 20, 1999
    Assignee: Bio-Energy Systems
    Inventors: John J. Majnarich, Timothy J. O'Brien
  • Patent number: 5529923
    Abstract: The present invention includes a substantially pure bacterium, Flavobacterium spp., which produces compositions having unique anti-tumor and anti-inflammatory properties. The present invention includes methods for treating tumors in mammals comprising administering to such mammals a therapeutically effective amount of a composition of the invention.
    Type: Grant
    Filed: February 14, 1994
    Date of Patent: June 25, 1996
    Assignee: Isomeric Corporation
    Inventors: Richard C. Honour, John J. Majnarich
  • Patent number: 5382428
    Abstract: A method is disclosed for preparing a purified extraction residue fraction (antigen) of a microorganism isolated from the blood or urine of a warm-blooded animal or tumor carried by a warm-blooded animal, the microorganism having the capacity to synthesize the polypeptide hormone known as "chorionic gonadotropin" in its total form or in its alpha and beta subunits. The purified extraction residue fraction is an activator and modulator of immunological response and is capable of evoking pronounced prophylactic and therapeutic effects against a variety of tumors in laboratory animals and man. The immune response is stimulated by administering an effective immuno-stimulating amount of the residue fraction and/or co-administering the residue fraction together with an adjuvant such as the complete Freund's adjuvant.
    Type: Grant
    Filed: April 11, 1989
    Date of Patent: January 17, 1995
    Assignees: John J. Mainarich, Virginia Livingston-Wheeler
    Inventors: Virginia Livingston-Wheeler, John J. Majnarich
  • Patent number: 4643970
    Abstract: Method for the production of chorionic gonadotropin (CG) with properties similar to those of human CG (HCG) from a microorganism or mutant thereof isolated by natural or hybridization procedure from the body or body extract carrier of a malignant tumor carrier and having the capacity to synthesize the polypeptide hormone known as human chorionic gonadotropin in its total form or in its sub-units (.alpha. & .beta.) which comprises:(a) culturing the microorganism or mutant thereof in a culture media;(b) incubating the culture of the microorganism or mutant thereof, whereby the microorganism or mutant thereof in vivo produces a crude material containing chorionic gonadotropin and/or its sub-units (.alpha. & .beta.);(c) separating the crude material containing chorionic gonadotropin and/or its sub-units (.alpha. & .beta.) from the culture media and the microorganism or mutant thereof.
    Type: Grant
    Filed: February 23, 1983
    Date of Patent: February 17, 1987
    Inventors: Virginia Livingston-Wheeler, John J. Majnarich
  • Patent number: 4410510
    Abstract: A method is disclosed for preparing a purified extraction residue fraction (antigen) of a microorganism isolated from the blood or urine of a warm-blooded animal or tumor carried by a warm-blooded animal, the microorganism having the capacity to synthesize the polypeptide hormone known as "chorionic gonadotropin" in its total form or in its alpha and beta subunits. The purified extraction residue fraction is an activator and modulator of immunological response and is capable of evoking pronounced prophylactic and therapeutic effects against a variety of tumors in laboratory animals and man. The immune response is stimulated by administering an effective immunostimulating amount of the residue fraction.
    Type: Grant
    Filed: April 20, 1981
    Date of Patent: October 18, 1983
    Assignee: Virginia Livingston-Wheeler
    Inventors: Virginia Livingston-Wheeler, John J. Majnarich